Donald Trump has been ridiculed for his comments about Ozempic and how he characterized the diabetic drug. He spoke in the Oval Office with RFK Jr on Monday (23 September) and questioned the ...
Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know. Eli Lilly's trial met its primary endpoints in the treatment of type 2 diabetes. The secondary ...
Looking ahead to 2026, new opportunities in private label and contract manufacturing are on the rise. Discover the key trends ...
A new daily pill may help people with obesity lose a significant amount of weight without the need for injections. The ...
Serena Williams’ candid reaction to a cotton display went viral, dividing fans and fueling a fiery online discussion.
Recently, a different weight loss drug, ecnoglutide, with an active ingredient of the peptide ecnoglutide, has been utilized ...
Medicare Part D coverage of glucagon-like peptide-1 receptor agonists— widely prescribed for diabetes and increasingly sought for obesity and related conditions— has remained broad. A research letter ...
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus ...
A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...
A new WTW survey reveals that over half of employers exceeded their healthcare budgets in 2024 and expect rising costs to continue, prompting a shift toward cost-containment strategies, vendor ...
New research from the Cleveland Clinic may explain why some people experience significant weight loss with GLP-1 medications.
Like many GLP-1 medications approved for diabetes, however, weight loss is a side effect of Rybelsus. “Data has shown modest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback